Abbott Vascular Ireland Receives Shingo Prize - 2014

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people. Abbott’s vascular division has an industry-leading pipeline and a comprehensive portfolio of market-leading products for cardiac and vascular care, including products for coronary artery disease, vessel closure, endovascular disease and structural heart disease.
Clonmel has been part of a global network of Abbott vascular manufacturing sites since 1998. AVD’s vision is “to improve the lives of patients and their families around the world through our passionate commitment to innovation in cardiac & vascular science.” This is driven by our five divisional strategic themes, which cascade through to everyone.
At our site, all activity is shaped by these themes, ensuring full strategic alignment, where the belief exists that our success is twinned with our unstinting commitment to operational excellence. Within this, our site is both positioned and recognised as the divisional “Centre of Excellence” for Stent and Drug Eluting Stent manufacturing.
The site has more than 1,000 employees primarily dedicated to manufacturing but also includes process development. The facility, which is more than 250,000 square feet sits on 19 acres and has three distinct areas manufacturing products for the treatment of coronary and endovascular diseases, namely:
DES (Drug Eluting Stent manufacturing);
Implants (Stent manufacturing);
SDS (Stent Delivery Systems or Catheter Manufacturing).

[@spiritofecstasy224]

Great Video! Very inspiring and informative! Thanks!

[@jacktatum321]

NMR